FERRIPEPTYL Trademark

Trademark Overview

On Wednesday, August 14, 2002, a trademark application was filed for FERRIPEPTYL with the United States Patent and Trademark Office. The USPTO has given the FERRIPEPTYL trademark a serial number of 76440518. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, July 11, 2014. This trademark is owned by Ferring B.V.. The FERRIPEPTYL trademark is filed in the Pharmaceutical Products category with the following description:

PHARMACEUTICAL PREPARATIONS FOR USE IN MODULATING HUMAN FERTILITY AND TREATING ONCOLOGICAL DISEASES
ferripeptyl

General Information

Serial Number76440518
Word MarkFERRIPEPTYL
Filing DateWednesday, August 14, 2002
Status710 - CANCELLED - SECTION 8
Status DateFriday, July 11, 2014
Registration Number3346533
Registration DateTuesday, December 4, 2007
Mark Drawing1000 - Typeset: Word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, June 29, 2004

Trademark Statements

Goods and ServicesPHARMACEUTICAL PREPARATIONS FOR USE IN MODULATING HUMAN FERTILITY AND TREATING ONCOLOGICAL DISEASES

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, July 11, 2014
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameFerring B.V.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
Address2132 JX Hoofddorp
NL
Party NameFerring B.V.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
Address2132 JX Hoofddorp
NL
Party NameFerring B.V.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
Address2132 JX Hoofddorp
NL

Trademark Events

Event DateEvent Description
Friday, July 11, 2014CANCELLED SEC. 8 (6-YR)
Tuesday, December 4, 2007REGISTERED-PRINCIPAL REGISTER
Friday, October 26, 20071(B) BASIS DELETED; PROCEED TO REGISTRATION
Thursday, September 20, 2007NOTICE OF ALLOWANCE CANCELLED
Monday, September 24, 2007PAPER RECEIVED
Wednesday, June 27, 2007EXTENSION 5 GRANTED
Thursday, March 15, 2007EXTENSION 5 FILED
Thursday, March 15, 2007PAPER RECEIVED
Monday, February 5, 2007EXTENSION 4 GRANTED
Thursday, September 21, 2006EXTENSION 4 FILED
Sunday, January 7, 2007PETITION GRANTED - EXTENSION REQUEST FILED
Monday, December 18, 2006PETITION TO REVIVE-RECEIVED
Monday, December 18, 2006PAPER RECEIVED
Friday, November 24, 2006ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Friday, November 24, 2006ABANDONMENT - NO USE STATEMENT FILED
Wednesday, April 19, 2006EXTENSION 3 GRANTED
Tuesday, March 21, 2006EXTENSION 3 FILED
Tuesday, March 21, 2006PAPER RECEIVED
Friday, October 14, 2005EXTENSION 2 GRANTED
Wednesday, September 21, 2005EXTENSION 2 FILED
Monday, September 26, 2005PAPER RECEIVED
Friday, May 6, 2005EXTENSION 1 GRANTED
Monday, March 21, 2005EXTENSION 1 FILED
Wednesday, March 23, 2005PAPER RECEIVED
Thursday, March 24, 2005PAPER RECEIVED
Tuesday, September 21, 2004NOA MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, June 29, 2004PUBLISHED FOR OPPOSITION
Wednesday, June 9, 2004NOTICE OF PUBLICATION
Friday, April 16, 2004APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, February 23, 2004CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, February 23, 2004PAPER RECEIVED
Wednesday, August 20, 2003NON-FINAL ACTION MAILED
Thursday, May 15, 2003CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, June 13, 2003CASE FILE IN TICRS
Thursday, May 15, 2003PAPER RECEIVED
Wednesday, November 13, 2002NON-FINAL ACTION MAILED
Friday, November 8, 2002ASSIGNED TO EXAMINER
Friday, November 1, 2002ASSIGNED TO EXAMINER
Monday, September 30, 2002PAPER RECEIVED

Related Keywords

ferripeptyl treating oncological diseases fertility human preparations modulating pharmaceutical